AS CONSUMERS, ADVOCATES and others prioritize their fight to lower prescription drug costs, insulin is usually first in line.  

Now, momentum to curb rising insulin costs seems to be building, with policymakers at the state and federal levels rolling out proposals seeking to provide diabetics some long-awaited financial relief. The questions now: What will materialize and how soon?

Continue reading for free

Sign in to read this story and receive the weekly roundup in your inbox.

Or

Success! Your account was created and you’re signed in.
Please visit My Account to manage your account.